Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catatonia | 3 | 2023 | 14 | 1.480 |
Why?
|
| Autism Spectrum Disorder | 4 | 2022 | 423 | 1.460 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 2 | 2021 | 22 | 1.230 |
Why?
|
| Autoimmune Diseases of the Nervous System | 2 | 2023 | 31 | 0.810 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 10 | 0.790 |
Why?
|
| Encephalitis | 2 | 2023 | 142 | 0.720 |
Why?
|
| Adolescent Development | 1 | 2020 | 72 | 0.620 |
Why?
|
| Electroconvulsive Therapy | 1 | 2018 | 16 | 0.560 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.490 |
Why?
|
| Medical Records | 1 | 2017 | 192 | 0.470 |
Why?
|
| Suicidal Ideation | 2 | 2023 | 584 | 0.460 |
Why?
|
| Puberty | 3 | 2022 | 137 | 0.450 |
Why?
|
| Body Mass Index | 2 | 2022 | 2447 | 0.450 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 638 | 0.380 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 426 | 0.370 |
Why?
|
| Self-Injurious Behavior | 2 | 2023 | 141 | 0.340 |
Why?
|
| Internship and Residency | 1 | 2017 | 1269 | 0.230 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 2968 | 0.220 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 469 | 0.220 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 150 | 0.210 |
Why?
|
| Child | 11 | 2023 | 22740 | 0.210 |
Why?
|
| Adolescent | 9 | 2023 | 22577 | 0.190 |
Why?
|
| Aggression | 1 | 2023 | 180 | 0.170 |
Why?
|
| Confusion | 1 | 2021 | 30 | 0.170 |
Why?
|
| Hospitalization | 2 | 2022 | 2461 | 0.160 |
Why?
|
| Delirium | 1 | 2021 | 105 | 0.160 |
Why?
|
| Female | 12 | 2023 | 79045 | 0.150 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 42 | 0.150 |
Why?
|
| Humans | 16 | 2023 | 145783 | 0.150 |
Why?
|
| Endocrine System Diseases | 1 | 2019 | 35 | 0.150 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2019 | 61 | 0.140 |
Why?
|
| Malnutrition | 1 | 2019 | 86 | 0.140 |
Why?
|
| Physical Examination | 1 | 2019 | 244 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2022 | 495 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 297 | 0.130 |
Why?
|
| Male | 10 | 2023 | 73011 | 0.130 |
Why?
|
| Communicable Diseases | 1 | 2019 | 166 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2018 | 168 | 0.130 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 192 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2023 | 869 | 0.120 |
Why?
|
| Sex Characteristics | 2 | 2020 | 789 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 286 | 0.120 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 196 | 0.110 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 5925 | 0.110 |
Why?
|
| Self Report | 1 | 2019 | 876 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 533 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2020 | 773 | 0.100 |
Why?
|
| Seizures | 1 | 2018 | 485 | 0.100 |
Why?
|
| Mental Health | 1 | 2020 | 796 | 0.100 |
Why?
|
| Mass Screening | 1 | 2021 | 1361 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2020 | 1171 | 0.080 |
Why?
|
| Parents | 1 | 2019 | 1407 | 0.080 |
Why?
|
| Poverty | 1 | 2013 | 529 | 0.070 |
Why?
|
| Motor Activity | 1 | 2013 | 718 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 2383 | 0.070 |
Why?
|
| Students | 1 | 2013 | 652 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 2123 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2017 | 3752 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2022 | 1491 | 0.060 |
Why?
|
| Risk Factors | 1 | 2017 | 10919 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2023 | 421 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 371 | 0.040 |
Why?
|
| Streptolysins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 12 | 0.040 |
Why?
|
| Self-Assessment | 1 | 2019 | 74 | 0.040 |
Why?
|
| Lorazepam | 1 | 2019 | 26 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2019 | 62 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 27 | 0.040 |
Why?
|
| United States | 1 | 2017 | 16126 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2019 | 56 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17330 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 147 | 0.030 |
Why?
|
| Comorbidity | 1 | 2023 | 1662 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 8078 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 643 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 222 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 1122 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2021 | 924 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1512 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2875 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1851 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 3418 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2020 | 995 | 0.020 |
Why?
|
| Adult | 1 | 2017 | 40881 | 0.020 |
Why?
|
| Texas | 1 | 2013 | 273 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 968 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 1509 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 6033 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5428 | 0.020 |
Why?
|
| Schools | 1 | 2013 | 449 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 6465 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 11868 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 10091 | 0.020 |
Why?
|